Literature DB >> 31864231

Genomics and bioinformatics as pillars of precision medicine in oncology.

Romina Canzoneri1, Ezequiel Lacunza1, Martín C Abba2.   

Abstract

The battle against cancer has advanced tremendously in the last thirty years and the survival rate has doubled. However, it is still difficult to achieve a generalized cure. The challenge is that cancer is not a unique disease; it is about dozens of different manifestations, even within the same tumor location. For systems biology, each solid tumor is a unique system characterized by its cellular heterogeneity, its interaction with the microenvironment in which it grows and develops, and its ability to adapt and modify it. Recent advances in understanding the molecular mechanisms that underlie cancer are transforming the diagnosis and treatment of the disease. In this sense, a growing set of treatments capable of attacking a specific tumor with higher efficiency has been developed, defining a new paradigm: the precision medicine in oncology. Genomics and bioinformatics are two fundamental pillars in this applied field. These technologies generate massive data (Big Data) that require analytical tools and trained personnel for the analysis, integration and transfer of the information to physicians. This presentation describes the concepts of personalized medicine, Big Data, the main advances in genomics and bioinformatics as well as their future perspectives and challenges.

Entities:  

Keywords:  Big Data; bioinformatics; genomics; precision medicine

Mesh:

Year:  2019        PMID: 31864231

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  4 in total

1.  Desk of the editor (Addendum Vol.12 Issue 1 E).

Authors:  K Harish
Journal:  Indian J Surg Oncol       Date:  2021-05-22

2.  EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.

Authors:  Yu Wang; Meiqi Song; Binbin Gao
Journal:  Comput Math Methods Med       Date:  2022-03-15       Impact factor: 2.238

3.  Role of Ultrasound Imaging in the Prediction of TRIM67 in Brain Metastases From Breast Cancer.

Authors:  Zhidong Xuan; Ting Ma; Yue Qin; Yajie Guo
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

4.  Role of TRIM22 in ulcerative colitis and its underlying mechanisms.

Authors:  Bin Ye; Zhongkai Lu
Journal:  Mol Med Rep       Date:  2022-06-08       Impact factor: 3.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.